This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Novagen Holding Corporation. Active years: 2009-2020.
Company Filing History:
Years Active: 2009-2020
Title: Innovations of Jizhi Li in Recombinant Human Interferon-like Proteins
Introduction
Jizhi Li is a prominent inventor based in Vancouver, Canada, known for his significant contributions to the field of biotechnology. He holds a total of seven patents, showcasing his innovative approach to medical treatments, particularly in the area of viral diseases and cancer.
Latest Patents
Among his latest patents is a method of treating diseases with recombinant human interferon-like proteins. This application focuses on recombinant human interferon-like proteins, where a recombinant protein created by gene shuffling technology is described. This protein exhibits enhanced anti-viral and anti-proliferative activities compared to naturally occurring human interferon-like alpha 2 (HuIFN-α2). The invention includes a polynucleotide encoding the protein and recombinant vectors and host cells that comprise the polynucleotide. The polynucleotide is preferably selected from a group of polynucleotides, each having a sequence at least 93% identical to SEQ ID: No. 1. The protein is selected from a group of proteins, each having an amino acid sequence at least 85% identical to SEQ ID No: 2. These proteins and compositions can be utilized for treating conditions responsive to interferon therapy, such as viral diseases and cancer.
Career Highlights
Jizhi Li is currently associated with Novagen Holding Corporation, where he continues to advance his research and development efforts. His work has been instrumental in the exploration of recombinant proteins and their therapeutic applications.
Collaborations
Some of his notable coworkers include Haitao Wang and Jing Xu, who have collaborated with him on various projects within the field of biotechnology.
Conclusion
Jizhi Li's innovative work in recombinant human interferon-like proteins represents a significant advancement in medical treatments for viral diseases and cancer. His contributions continue to impact the field of biotechnology positively.